This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
ASXL1, TP53 and IKZF3 mutations are present in the chronic phase and blast crisis of chronic myeloid leukemia
Blood Cancer Journal Open Access 08 November 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. New Engl J Med 2005; 352: 254–266.
Falini B, Mecucci C, Saglio G, Lo Coco F, Diverio D, Brown P et al. NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia. Haematologica 2008; 93: 439–442.
Falini B, Nicoletti I, Martelli MF, Mecucci C . Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features. Blood 2007; 109: 874–885.
Schlenk RF, Dohner K, Krauter J, Frohling S, Corbacioglu A, Bullinger L et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008; 358: 1909–1918.
Arber D, Brunning R, Le Beau M, Falini B, Vardiman J, Porwit A et al. Acute myeloid leukemia (AML) and related precursor neoplasms. In: IARC (ed). WHO Classification of Tumors of the Hematopoietic and Lymphoid Tissues. Lyon, France, 2008, pp 109–145.
Pileri SA, Ascani S, Cox MC, Campidelli C, Bacci F, Piccioli M et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia 2007; 21: 340–350.
Pasqualucci L, Li S, Meloni G, Schnittger S, Gattenlohner S, Liso A et al. NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin? Leukemia 2008; 22: 1459–1463.
Yin CC, Medeiros LJ, Glassman AB, Lin P . t(8;21)(q22;q22) in blast phase of chronic myelogenous leukemia. Am J Clin Pathol 2004; 121: 836–842.
Merzianu M, Medeiros LJ, Cortes J, Yin C, Lin P, Jones D et al. inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases. Am J Clin Pathol 2005; 124: 807–814.
Acknowledgements
This work was supported by Centro Interdipartimentale per la Ricerca sul Cancro ‘G. Prodi’, European LeukemiaNet, COFIN 2002-2003 (Professor SA Pileri), FIRB/RFO (Professor SA Pileri and Professor PL Zinzani), AIRC, Progetto Strategico di Ateneo 2006 (Professor SA Pileri and Dr Piccaluga), Fondazione Cassa di Risparmio in Bologna, and BolognAIL grants.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Piccaluga, P., Sabattini, E., Bacci, F. et al. Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia. Leukemia 23, 1370–1371 (2009). https://doi.org/10.1038/leu.2009.95
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2009.95
This article is cited by
-
NPM1 mutations occur rarely or not at all in chronic myeloid leukaemia patients in chronic phase or blast crisis
Leukemia (2013)
-
ASXL1, TP53 and IKZF3 mutations are present in the chronic phase and blast crisis of chronic myeloid leukemia
Blood Cancer Journal (2013)
-
Development of acute myeloid leukemia with NPM1 mutation, in Ph-negative clone, during treatment of CML with imatinib
Leukemia (2012)